Tinea capitis has a worldwide distribution. The disease predominantly affects children aged 1 to 10 years, but infections in adults are occasionally seen. These infections can spread among family ...

MAKING THE DIAGNOSIS Each nodule on the patient’s scalp was approximately 1 cm in diameter with a central punctum. The lesions were of indeterminate etiology, but given the patient’s travel history, ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." If you find yourself itching your head, you may have dry skin or irritating dandruff. While these are ...

A 42-year-old white woman presents with multiple lesions on the face and scalp. They began to appear in her 20s and have been increasing in number. The scalp lesions are painful at times, and she is ...

Dissecting cellulitis of the scalp is a rare skin condition that causes hair loss, pain, and scarring. While there’s no cure, treatment may include oral and topical medications and antiseptic shampoos ...

Dr. Carolina Chiou (Ophthalmology): A 78-year-old man was admitted to this hospital because of a rash on the forehead and frontal scalp and edema of the left eyelids. The patient had been well until 3 ...

In this study, roughly 1 in 5 patients with psoriasis went on to develop severe disease over a median of 9.6 years of follow-up. Patients with plaque-type disease with a score above 3 on the Physician ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A 6-month-old boy presented with a rash ...

Scalp rosacea is an uncommon skin condition causing discoloration or redness and pus-filled bumps on the top of the head. It tends to affect males in an atypical pattern. Rosacea is a chronic skin ...

A 3-day-old full-term female infant with no concerning prenatal history was evaluated at her pediatrician’s office for a routine follow-up visit after hospital discharge. Her parents reported a small ...

On Friday, Johnson & Johnson (NYSE:JNJ) announced that treatment with Tremfya (guselkumab) resulted in clear or almost clear skin in the majority of adults with low body surface area (BSA) moderate ...